NCLAT: Can’t Dismiss Restoration App. if Filed in 30 Days from Date of Dismissal of Original App.  ||  Delhi HC: Communication between Parties through Whatsapp Constitute Valid Agreement  ||  Delhi HC Seeks Response from Govt. Over Penalties on Petrol Pumps Supplying Fuel to Old Vehicles  ||  Centre Notifies "Unified Waqf Management, Empowerment, Efficiency and Development Rules, 2025"  ||  Del. HC: Can’t Reject TM Owner’s Claim Merely because Defendant Could have Sought Removal of Mark  ||  Bombay HC: Cannot Treat Sole Director of OPC, Parallelly with Separate Legal Entity  ||  Delhi HC: Can Apply 'Family of Marks' Concept to Injunct Specific Marks  ||  HP HC: Can’t Set Aside Ex-Parte Decree for Mere Irregularity  ||  Cal. HC: Order by HC Bench Not Conferred With Determination by Roster is Void  ||  Calcutta HC: Purchase Order Including Arbitration Agreement to Prevail Over Tax Invoice Lacking it    

Search Results for Tag : trastuzumab

News

Delhi HC Permits Sale and Manufacture of Breast Cancer Drug Trastuzumab(26.04.2016)

Delhi HC has allowed sale and manufacture of breast cancer drug trastuzumab by Biocon and Reliance Life Sciences, with certain restrictions.

Tags : Delhi HC, Breast Cancer Drug , Trastuzumab



Delhi High Court to Roche: Can’t Hang on to Breast Cancer Drug For Lifetime(23.02.2017)

Delhi High Court has told Swiss pharma major Roche that it “cannot hang on to” breast cancer drug Trastuzumab, innovated by it, for rest of its life a.....

Tags : Delhi High Court, Trastuzumab, Breast Cancer



Delhi HC Restrains Reliance from Launching Copy of Roche's Breast Cancer Drug(05.11.2015)

Delhi High Court has restrained Reliance Life Sciences from launching a copy of Swiss Pharma Company Roche's breast cancer drug trastuzumab.

Tags : Delhi High Court , Reliance Life Sciences, breast cancer drug trastuzumab



Judgments

Delhi High Court to delve into Drug Controller irregularities(25.04.2016)

The Delhi High Court deferred a dispute regarding the development, classification and promotion of bio-similar drugs to 2 June 2016. Brought by Roche .....

Tags : trastuzumab, bio-similar, dcgi, roche



Disclaimer | Copyright 2025 - All Rights Reserved